Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) , the persisting deficiencies and future prospects of using lncRNAs as
clinical biomarkers and therapeutic targets
. The developed software can be used as a separate application and be built as a module into the
clinical decision
Sufianov, A.,
Bessonova, M.,
Begliarzade, S.,
Kudriashov, V.,
Danilov, A.,
Ilyasova, T.,
Yaolou, W.,
Nafikova, R.,
Beylerli, O. (2023) and
clinical applications are worth further examination. This article reviews the recent research on the role
Usman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) (lncRNAs) and circular
RNAs (circRNAs) into
clinical medicine as biomarkers and therapeutic targets.
investigations and
clinical
trials employed enhanced MSCs-dependent therapies in treatment of inflammatory